[Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002271:Carbutamide / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003692:Delayed-Action Preparations; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005905:Glyburide / Q000008:administration & dosage* / Q000627:therapeutic use; D006029:Glycosuria; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D010629:Phenformin / Q000008:administration & dosage* / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D014280:Triglycerides; D008687:Metformin; D002784:Cholesterol; D014044:Tolbutamide; D010629:Phenformin; D002271:Carbutamide; D005905:Glyburide
Terapia antidiabetica orale con glibenclamide e fenformina ritardo in associazione fissa